PT - JOURNAL ARTICLE AU - Linlin Bao AU - Wei Deng AU - Baoying Huang AU - Hong Gao AU - Jiangning Liu AU - Lili Ren AU - Qiang Wei AU - Pin Yu AU - Yanfeng Xu AU - Feifei Qi AU - Yajin Qu AU - Fengdi Li AU - Qi Lv AU - Wenling Wang AU - Jing Xue AU - Shuran Gong AU - Mingya Liu AU - Guanpeng Wang AU - Shunyi Wang AU - Zhiqi Song AU - Linna Zhao AU - Peipei Liu AU - Li Zhao AU - Fei Ye AU - Huijuan Wang AU - Weimin Zhou AU - Na Zhu AU - Wei Zhen AU - Haisheng Yu AU - Xiaojuan Zhang AU - Li Guo AU - Lan Chen AU - Conghui Wang AU - Ying Wang AU - Xinming Wang AU - Yan Xiao AU - Qiangming Sun AU - Hongqi Liu AU - Fanli Zhu AU - Chunxia Ma AU - Lingmei Yan AU - Mengli Yang AU - Jun Han AU - Wenbo Xu AU - Wenjie Tan AU - Xiaozhong Peng AU - Qi Jin AU - Guizhen Wu AU - Chuan Qin TI - The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice AID - 10.1101/2020.02.07.939389 DP - 2020 Jan 01 TA - bioRxiv PG - 2020.02.07.939389 4099 - http://biorxiv.org/content/early/2020/02/28/2020.02.07.939389.short 4100 - http://biorxiv.org/content/early/2020/02/28/2020.02.07.939389.full AB - Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the Corona Virus Disease 2019 (COVID-19) cases in China has become a public health emergency of international concern (PHEIC). Based on angiotensin converting enzyme 2 (ACE2) as cell entry receptor of SARS-CoV, we used the hACE2 transgenic mice infected with SARS-CoV-2 to study the pathogenicity of the virus. Weight loss and virus replication in lung were observed in hACE2 mice infected with SARS-CoV-2. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes and monocytes in alveolar interstitium, and accumulation of macrophages in alveolar cavities. Viral antigens were observed in the bronchial epithelial cells, alveolar macrophages and alveolar epithelia. The phenomenon was not found in wild type mice with SARS-CoV-2 infection. The pathogenicity of SARS-CoV-2 in hACE2 mice was clarified and the Koch’s postulates were fulfilled as well, and the mouse model may facilitate the development of therapeutics and vaccines against SARS-CoV-2.